ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,000 | -28.1% | 24,358 | +3.2% | 0.00% | – |
| Q2 2023 | $32,000 | -97.4% | 23,593 | -28.0% | 0.00% | -100.0% |
| Q3 2020 | $1,217,000 | +12.8% | 32,753 | +51.9% | 0.01% | 0.0% |
| Q2 2020 | $1,079,000 | +58.7% | 21,568 | -10.1% | 0.01% | +50.0% |
| Q1 2020 | $680,000 | -50.9% | 23,993 | -2.7% | 0.00% | -50.0% |
| Q4 2019 | $1,386,000 | +80.2% | 24,668 | +9.4% | 0.01% | +100.0% |
| Q3 2019 | $769,000 | -41.0% | 22,549 | -19.8% | 0.00% | -50.0% |
| Q2 2019 | $1,304,000 | +69.4% | 28,115 | +46.5% | 0.01% | +60.0% |
| Q1 2019 | $770,000 | -6.7% | 19,189 | +6.8% | 0.01% | -16.7% |
| Q4 2018 | $825,000 | +6.0% | 17,961 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $778,000 | – | 17,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |